Cargando…

The Future of Sleeve Gastrectomy

The International Diabetes Federation has recently published a position statement on bariatric surgery. Facing a global diabetes crisis, it has added various types of surgery on the gastrointestinal tract as powerful options among the armamentarium to normalise glycaemia, avoid regular medications a...

Descripción completa

Detalles Bibliográficos
Autor principal: Gagner, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813458/
https://www.ncbi.nlm.nih.gov/pubmed/29632587
http://dx.doi.org/10.17925/EE.2016.12.01.37
_version_ 1783300201051586560
author Gagner, Michel
author_facet Gagner, Michel
author_sort Gagner, Michel
collection PubMed
description The International Diabetes Federation has recently published a position statement on bariatric surgery. Facing a global diabetes crisis, it has added various types of surgery on the gastrointestinal tract as powerful options among the armamentarium to normalise glycaemia, avoid regular medications and decrease costs in severely obese patients. Laparoscopic sleeve gastrectomy has been shown to be effective for the treatment of type 2 diabetes, with extremely low mortality and acceptable morbidity. It decreases caloric consumption, modifies gut hormones, changes gastric emptying, and lowers glycaemia. In the long term, if recurrences in weight or diabetes occur, it can be converted to a duodenal switch, potentially reaching 90% of patients with partial or complete remission.
format Online
Article
Text
id pubmed-5813458
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Touch Medical Media
record_format MEDLINE/PubMed
spelling pubmed-58134582018-04-09 The Future of Sleeve Gastrectomy Gagner, Michel Eur Endocrinol Obesity and Weight Management Editorial The International Diabetes Federation has recently published a position statement on bariatric surgery. Facing a global diabetes crisis, it has added various types of surgery on the gastrointestinal tract as powerful options among the armamentarium to normalise glycaemia, avoid regular medications and decrease costs in severely obese patients. Laparoscopic sleeve gastrectomy has been shown to be effective for the treatment of type 2 diabetes, with extremely low mortality and acceptable morbidity. It decreases caloric consumption, modifies gut hormones, changes gastric emptying, and lowers glycaemia. In the long term, if recurrences in weight or diabetes occur, it can be converted to a duodenal switch, potentially reaching 90% of patients with partial or complete remission. Touch Medical Media 2016-03 2016-03-15 /pmc/articles/PMC5813458/ /pubmed/29632587 http://dx.doi.org/10.17925/EE.2016.12.01.37 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by/2.5/ This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit.
spellingShingle Obesity and Weight Management Editorial
Gagner, Michel
The Future of Sleeve Gastrectomy
title The Future of Sleeve Gastrectomy
title_full The Future of Sleeve Gastrectomy
title_fullStr The Future of Sleeve Gastrectomy
title_full_unstemmed The Future of Sleeve Gastrectomy
title_short The Future of Sleeve Gastrectomy
title_sort future of sleeve gastrectomy
topic Obesity and Weight Management Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813458/
https://www.ncbi.nlm.nih.gov/pubmed/29632587
http://dx.doi.org/10.17925/EE.2016.12.01.37
work_keys_str_mv AT gagnermichel thefutureofsleevegastrectomy
AT gagnermichel futureofsleevegastrectomy